|
Shinva EK-I Ear Surgical Instruments Set ZO199
Ear surgical instrument sets are bought as configurations, not isolated tools. The Shinva EK-I ZO199 illustrates why component lists and sterilization workflows must be confirmed before quotation.
The Shinva EK-I Ear Surgical Instruments Set ZO199 is identified as a professional surgical instrument or reusable medical accessory for hospitals, operating rooms, specialist departments, and distributors.
Its supplied component list includes a raspatory 160×1 curved, ear curette 160×1.8 single, curette 160×2 single, ear knife 160×2.5×45°, and knife 160×2.4 sharp.
Those entries describe individual set elements, but the input does not confirm materials, sterilization method, or procedure-specific compatibility. Buyers should treat included components and sizes as configuration details to verify.
Typical stated uses cover procedure-specific preparation and intervention, department instrument-set procurement, and sterile processing or reusable-instrument workflows.
Because final specifications, certifications, warranty, and regulatory availability vary by version and destination, procurement should confirm the intended configuration before order.
MOQ, price, lead time, documentation, and international delivery terms also require a formal quotation. The set’s fit depends on how the hospital’s reprocessing and inventory systems handle reusable instruments.
For distributors, the main risk is assuming that a model number guarantees a fixed bill of materials. A documented configuration review is the practical starting point.
Why it matters:
Set-level medical procurement succeeds when component lists, reprocessing requirements, and destination-market rules are confirmed in writing before purchase.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
ScientificChina is an independent commercial platform and is not affiliated with or endorsed by any Chinese government agency or public institution.
|
|